Edition:
United States

Vertex Pharmaceuticals Inc (VRTX.O)

VRTX.O on Nasdaq

159.76USD
20 Nov 2018
Change (% chg)

$-1.31 (-0.81%)
Prev Close
$161.07
Open
$161.35
Day's High
$161.92
Day's Low
$157.29
Volume
1,658,171
Avg. Vol
1,293,501
52-wk High
$194.92
52-wk Low
$136.50

Chart for

About

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $43,524.09
Shares Outstanding(Mil.): 255.56
Dividend: --
Yield (%): --

Financials

  VRTX.O Industry Sector
P/E (TTM): 68.20 79.36 29.34
EPS (TTM): 2.50 -- --
ROI: 21.87 -0.30 13.58
ROE: 27.54 -2.98 15.11

Vertex cystic fibrosis drug gets expanded approval for use in infants

U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.

Aug 15 2018

Vertex cystic fibrosis drug gets expanded approval for use in infants

Aug 15 U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.

Aug 15 2018

Earnings vs. Estimates